- Home
- CLF vs RYTM Comparison
CLF vs RYTM Comparison
Compare CLF & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLF
- RYTM
- Stock Information
- Founded
- CLF 1847
- RYTM 2008
- Country
- CLF United States
- RYTM United States
- Employees
- CLF N/A
- RYTM N/A
- Industry
- CLF Metal Mining
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- CLF Basic Materials
- RYTM Health Care
- Exchange
- CLF Nasdaq
- RYTM Nasdaq
- Market Cap
- CLF 5.2B
- RYTM 6.9B
- IPO Year
- CLF N/A
- RYTM 2017
- Fundamental
- Price
- CLF $11.39
- RYTM $102.12
- Analyst Decision
- CLF Buy
- RYTM Strong Buy
- Analyst Count
- CLF 9
- RYTM 13
- Target Price
- CLF $10.52
- RYTM $101.92
- AVG Volume (30 Days)
- CLF 16.5M
- RYTM 570.8K
- Earning Date
- CLF 11-03-2025
- RYTM 11-04-2025
- Dividend Yield
- CLF N/A
- RYTM N/A
- EPS Growth
- CLF N/A
- RYTM N/A
- EPS
- CLF N/A
- RYTM N/A
- Revenue
- CLF $18,457,000,000.00
- RYTM $156,287,000.00
- Revenue This Year
- CLF $3.18
- RYTM $44.69
- Revenue Next Year
- CLF $6.42
- RYTM $63.53
- P/E Ratio
- CLF N/A
- RYTM N/A
- Revenue Growth
- CLF N/A
- RYTM 53.55
- 52 Week Low
- CLF $5.63
- RYTM $45.91
- 52 Week High
- CLF $14.34
- RYTM $106.52
- Technical
- Relative Strength Index (RSI)
- CLF 66.48
- RYTM 60.62
- Support Level
- CLF $10.06
- RYTM $101.45
- Resistance Level
- CLF $11.10
- RYTM $106.52
- Average True Range (ATR)
- CLF 0.40
- RYTM 3.12
- MACD
- CLF 0.02
- RYTM -0.43
- Stochastic Oscillator
- CLF 99.35
- RYTM 65.84
About CLF Cleveland-Cliffs Inc.
Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.